Evidence map›Paper›PMID 41094747›Full record

SynthesisAlcohol, clinical & experimental research2025

Potential TMS biomarkers for GABA

Chiara Montemitro, Sara Terrezza, Federico Maruottolo, Andrea Costumati, Markus Heilig

Abstract readSystematic Review
PubMed Full text at PMC Publisher
In one paragraph

Synthesis in Alcohol, clinical & experimental research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Potential TMS biomarkers for GABAAlcohol, clinical & experimental research · 2025
    Pooled it
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Chiara MontemitroCenter for Social and Affective Neuroscience, Linköping University, Linköping, Sweden.ORCID https://orcid.org/0000-0002-3280-1895
Sara TerrezzaDepartment of Psychiatry, University of Parma, Parma, Italy.
Federico MaruottoloDepartment of Psychiatry, University of Parma, Parma, Italy.
Andrea CostumatiDepartment of Psychiatry, University of Parma, Parma, Italy.
Markus HeiligCenter for Social and Affective Neuroscience, Linköping University, Linköping, Sweden.

Funding

Knut och Alice Wallenbergs StiftelseSwedish Research Council 2019-01138 VR
6 · The paper itself

Abstract

Alcohol use disorder (AUD) is a major global health issue, with current treatments often limited in efficacy and patient acceptance. The gamma-aminobutyric acid (GABA) system, particularly GABA

Indexed as

AlcoholismReceptors, GABA-BTranscranial Magnetic StimulationBiomarkersGABA-B Receptor AgonistsHumansBiomarkersGABA-B Receptor AgonistsReceptors, GABA-Balcohol use disorderbaclofencortical inhibitiongamma‐aminobutyric acidtranscranial magnetic stimulation

Identifiers

PMID41094747
PMCPMC12721484

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.